Superficial siderosis of the central nervous system

Superficial siderosis is a rare condition which results from deposition of haemosiderin along the leptomeninges, with eventual neurological dysfunction.

Terminology

The literature is divided as to whether the term superficial siderosis should be confined to cases where there is no history of symptomatic subarachnoid haemorrhage, or whether it is a blanket term referring to the superficial deposition of haemosiderin, irrespective of cause. 

For the purpose of this article, we take the laterlatter definition.

Epidemiology

As there are many causes of recurrent or extensive subarachnoid haemorrhage, the demographics are ill-defined and represent those of the underlying cause. Cases have been reported in patients between 14 and 77 years of age ⁵. Overall, there is a male predilection (M:F 3:1) ^2,5.

Clinical presentation

Symptoms can vary depending on the distribution of haemosiderin deposition. Typical symptoms include ^2-5:

• sensorineural hearing loss
  • most common, found in ~95% of patients
  • bilateral and gradual
• cerebellar dysfunction (ataxia): ~90%
• pyramidal signs: ~75%
• other less common findings include
  • dementia
  • bladder incontinence
  • other cranial nerve dysfunction
  • sensory deficits

It is important to realise that the degree of imaging abnormality does not always correlate with the degree of clinical impairment ⁴.

Pathology

Superficial siderosis is thought to result from recurrent occult subarachnoid bleeds although the source of bleeding is not usually identified on imaging ¹. Although it is common to see a small amount of haemosiderin deposition at the margins of a previous haemorrhage or surgical resection margin, a single episode of subarachnoid haemorrhage is usually not sufficient to result in this condition ².

Vestibulocochlear nerve (CN VIII) dysfunction resulting in a sensorineural hearing loss is believed to be due to the combination of a long cisternal course (thus with ample exposure to the subarachnoid space) and the susceptibility of microglial cells (providing the myelin for the nerve(which have a role in myelination) to be damaged by iron compounds ⁴.

Aetiology

A cause of recurrent subarachnoid haemorrhage is present in ~50% of cases ^1-6,8:

• spinal dural defects
  • traumatic cervical nerve root avulsion
  • dural defect with spinal CSF collections/spinal cyst ^9-10
  • post-operative pseudomeningocoele
• intracranial neoplasms
  • occult small ependymoma
  • oligodendroglioma
  • astrocytoma
• vascular abnormalities
  • arteriovenous malformation (AVM)
    • micro-arteriovenous malformation
  • aneurysm
  • fragile capillary regrowth after brain surgery ²
• cerebral amyloid angiopathy: seen in 60% of patients⁷
• idiopathic: up to 46% of the timecases ²

Radiographic features

MRI

MRI is the modality of choice for assessment and diagnosis of superficial siderosis. The findings are characteristic, with all pial and ependymal surfaces (particularlycoated with low signal haemosiderin, particularly those of the brainstem and cerebellum: (the cerebellar vermis and folia of the cerebellum are excellent locations to identifyfor identifying subtle deposits) coated with low signal haemosiderin. In long standing-standing cases, cerebellar atrophy may also be present.

• T1: low signal
• T2: low signal
• GE (gradient echo): low signal with blooming
• SWI: low signal with blooming

As part of the work up for superficial siderosis, if no lesion is identified in the intracranial compartment, then imaging of the wholeentire spinal canal should be performed (e.g. superficial haemosiderosis due to myxopapillary ependymoma) ⁵.

Angiography

Usually unrewarding and; will not demonstrate a point of bleeding ¹.

Treatment and prognosis

Unfortunately, no proven direct treatment existexists for established siderosis, and workup is focused on identifying the causative lesion, although often even this is not possible. Iron chelating agents have been tried with limited anecdotal success ⁶.

When no correctable cause is identified, signs and symptoms are slowly progressive.